MétaCan
Menu
← Back to cohort
Record W4412080117 · doi:10.1101/2025.07.07.25330740

Medication Exposure and Neurodegenerative Disease Risk Across National Biobanks

2025· preprint· en· W4412080117 on OpenAlexaff
Kristin Levine, Lana Sargent, Emma N. Somerville, Vanessa Pitz, Elvin T. Price, Sara Bandrés‐Ciga, Emily Simmonds, Caroline Jonson, Lara M. Lange, Alastair J. Noyce, Valentina Escott‐Price, Hirotaka Iwaki, Kendall Van Keuren‐Jensen, Luigi Ferrucci, Andrew Singleton, Mike A. Nalls, Hampton L. Leonard

Bibliographic record

VenuemedRxiv · 2025
Typepreprint
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsMontreal Neurological Institute and Hospital
FundersNational Institute on AgingNational Institutes of HealthAmazon Web ServicesU.S. Department of Health and Human Services
KeywordsBiobankDiseaseEnvironmental healthMedicineBioinformaticsBiologyPathology

Abstract

fetched live from OpenAlex

Abstract Advanced age, genetics, and environmental exposures are leading contributors to the development of neurodegenerative disorders (NDD). In this study, we used data from the UK Biobank (UKB) and the All of Us (AoU) initiative to determine if exposure to specific medications are associated with an increased or decreased risk of NDD, including Alzheimer’s (AD), Parkinson’s disease (PD), and all-cause dementia (DEM). We investigated the associations between these diseases and prescription drug exposures through an unbiased analysis, assessing both lifetime risk and risk from exposures occurring more than ten years before diagnosis, while also accounting for comorbid conditions. Methods Cox proportional hazard models were used to evaluate both lifetime and ten-year lag-associated risks of developing a NDD following exposure to specific prescription medications. This analysis followed a two-stage design, incorporating separate discovery and replication cohorts sourced from national-scale biobanks. Findings We pulled data from over 700,000 health records from individuals of European ancestry to survey a total of 480 prescription medication exposures. After multiple test corrections, we found 241 significant associations between medication exposure and risk of NDDs in our discovery cohort, with 157 of these replicated in an independent dataset. After adjusting for potential comorbidities, 15 medication-NDD associations remained significant, some of which were attenuated after accounting for APOE -ε4 status. Most of these significant pairings were associated with increased risk, however, two antibiotics, one proton pump inhibitor, and one statin had replicated effects inversely associated with disease risk. Interpretation While correlation does not imply causation and some associations may be driven by medications used to treat prodromal stages of disease, we have utilized large, unbiased datasets to identify and replicate associations between commonly prescribed medications and NDD risk. Additional longitudinal and mechanistic investigations are warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.039
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.030
Threshold uncertainty score0.066

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.039
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0030.008
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.003
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.312
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuemedRxiv→Same topicLipoproteins and Cardiovascular Health→French-language works237,207→